drugset / Trial / NCT05457270

A Study to Assess the Relative Bioavailability and Safety of Different Formulations of AZD4831 in Fasted State in Healthy Volunteers.

NCT05457270 ↗

Phase 1 Completed 30 enrolled AstraZeneca Parexel · collab
RandomizedCrossoverOpen-labelTreatment

Summary

A study to assess the relative bioavailability and safety of different formulations of AZD4831 in fasted state in healthy volunteers.

Timeline

Start
2022-08-11
Primary completion
2022-10-17
Completion
2022-10-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Mitiperstat Small molecule — Oral

Indications

No indication recorded.